Cargando…
Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906454/ https://www.ncbi.nlm.nih.gov/pubmed/29670171 http://dx.doi.org/10.1038/s41598-018-24838-6 |
| _version_ | 1783315371331158016 |
|---|---|
| author | Dzyurkevich, Mikhail S. Babkov, Denis A. Shtyrlin, Nikita V. Mayka, Olga Yu. Iksanova, Alfiya G. Vassiliev, Pavel M. Balakin, Konstantin V. Spasov, Alexander A. Tarasov, Vadim V. Barreto, George Shtyrlin, Yurii G. Aliev, Gjumrakch |
| author_facet | Dzyurkevich, Mikhail S. Babkov, Denis A. Shtyrlin, Nikita V. Mayka, Olga Yu. Iksanova, Alfiya G. Vassiliev, Pavel M. Balakin, Konstantin V. Spasov, Alexander A. Tarasov, Vadim V. Barreto, George Shtyrlin, Yurii G. Aliev, Gjumrakch |
| author_sort | Dzyurkevich, Mikhail S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5906454 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59064542018-04-30 Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus Dzyurkevich, Mikhail S. Babkov, Denis A. Shtyrlin, Nikita V. Mayka, Olga Yu. Iksanova, Alfiya G. Vassiliev, Pavel M. Balakin, Konstantin V. Spasov, Alexander A. Tarasov, Vadim V. Barreto, George Shtyrlin, Yurii G. Aliev, Gjumrakch Sci Rep Author Correction Nature Publishing Group UK 2018-04-19 /pmc/articles/PMC5906454/ /pubmed/29670171 http://dx.doi.org/10.1038/s41598-018-24838-6 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Author Correction Dzyurkevich, Mikhail S. Babkov, Denis A. Shtyrlin, Nikita V. Mayka, Olga Yu. Iksanova, Alfiya G. Vassiliev, Pavel M. Balakin, Konstantin V. Spasov, Alexander A. Tarasov, Vadim V. Barreto, George Shtyrlin, Yurii G. Aliev, Gjumrakch Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus |
| title | Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus |
| title_full | Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus |
| title_fullStr | Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus |
| title_full_unstemmed | Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus |
| title_short | Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus |
| title_sort | author correction: pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906454/ https://www.ncbi.nlm.nih.gov/pubmed/29670171 http://dx.doi.org/10.1038/s41598-018-24838-6 |
| work_keys_str_mv | AT dzyurkevichmikhails authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus AT babkovdenisa authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus AT shtyrlinnikitav authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus AT maykaolgayu authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus AT iksanovaalfiyag authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus AT vassilievpavelm authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus AT balakinkonstantinv authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus AT spasovalexandera authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus AT tarasovvadimv authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus AT barretogeorge authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus AT shtyrlinyuriig authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus AT alievgjumrakch authorcorrectionpyridoxinedipharmacophorederivativesaspotentglucokinaseactivatorsforthetreatmentoftype2diabetesmellitus |